Preventing HIV with injectable lenacapavir: WHO recommendation
The World Health Organization (WHO) released new guidelines in July recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre‐exposure prophylaxis (PrEP) option for HIV prevention. The landmark policy could help reshape the global HIV response, according to WHO. The guidelines were issued at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, in Kigali, Rwanda.
Authors
- Alison Knopf
Publication Details
- Journal
- The Brown University Child and Adolescent Behavior Letter
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1002/cbl.30898
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00